
A total of 25 people have been killed in new attacks by the Israeli army in the Gaza Strip despite the current ceasefire, the Hamas-controlled health authority said on Wednesday.
The announcement came after the Israeli Defense Forces (IDF) said it had targeted Hamas positions across Gaza in response to several "terrorists" opening fire on an area in Khan Younis where Israeli soldiers were deployed.
"This action constitutes a violation of the ceasefire agreement," the IDF said, adding that no Israeli troops were injured.
Khan Younis is the largest city in the southern Gaza Strip.
The Palestinian news agency WAFA reported that 10 people were killed and dozens wounded in an Israeli strike on a building used by a Hamas-controlled authority in Gaza City, in the north. Three minors were among the dead, according to the report.
The health authority said more than 70 people were injured in the latest attacks.
Residents told dpa on Wednesday evening that no further strikes were occurring at that time.
Violent incidents have been reported repeatedly since the ceasefire began on October 10.
LATEST POSTS
- 1
Experience Sports in Dubai: A Daredevil's Aide - 2
Los Angeles County sees significant uptick in norovirus cases, officials say - 3
Pick the Ideal Family Feline Variety for Your Home - 4
Unraveling the Specialty of Picking Your Ideal Travel Objective - 5
‘RuPaul's Drag Race’ Season 18: How to watch without cable, premiere time, cast list and more
CDC vaccine panel votes to remove universal hepatitis B birth dose recommendation
An Extended time of Careful Nurturing: Individual Bits of knowledge on Bringing up Kids
What to know about the hepatitis B shot — and why Trump officials are targeting it
St George Mining hits record 178m high-grade intercept at Araxá, reinforcing global scale
Find the Captivating Professional flowerbeds of the US
Climbing Mount Everest: An Individual Victory
African Forests Have Become a Source of Carbon Emissions
Timothy Busfield turns himself in to face child sexual abuse charges in New Mexico
Regeneron's experimental therapy combo effective in untreated cancer patients












